Swiss National Bank
EVMN

Swiss National Bank’s Evommune Inc EVMN Stock Holding History

Swiss National Bank’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
+21,700
New +$504K ﹤0.01% 2299

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Swiss National Bank's EVMN Position: Q2 2026 in Review

Swiss National Bank opened a new position in Evommune Inc (EVMN) in Q2 2026: 21,700 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #2299 among its holdings.

105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Swiss National Bank held 21,700 shares of Evommune Inc worth $288K as of Q2 2026.
  • Evommune Inc was a new Swiss National Bank position in Q2 2026.
  • Evommune Inc made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2299 holding.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.